{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:37:45Z","timestamp":1761745065518},"reference-count":35,"publisher":"Pharmaceutical Society of Japan","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,12,1]]},"DOI":"10.1248\/bpb.b19-00668","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T12:07:47Z","timestamp":1575288467000},"page":"2095-2101","source":"Crossref","is-referenced-by-count":4,"title":["Improvement Effects of Trehangelin A on High-Fat Diet Causing Metabolic Clinical Conditions"],"prefix":"10.1248","volume":"42","author":[{"given":"Hiroki","family":"Ishikawa","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ino","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Kitasato Institute for Life Sciences, Kitasato University"},{"name":"Graduate School of Pharmaceutical Sciences, Kitasato University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Kitasato Institute for Life Sciences, Kitasato University"},{"name":"Graduate School of Pharmaceutical Sciences, Kitasato University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u014dko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Kitasato Institute for Life Sciences, Kitasato University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikara","family":"Kohda","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"\u014cmura","sequence":"additional","affiliation":[{"name":"Kitasato Institute for Life Sciences, Kitasato University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Morris MJ, Beilharz JE, Maniam J, Reichelt AC, Westbrook RF. Why is obesity such a problem in the 21st century? The intersection of palatable food, cues and reward pathways, stress, and cognition. <i>Neurosci. Biobehav. Rev.<\/i>, <b>58<\/b>, 36\u201345 (2015).","DOI":"10.1016\/j.neubiorev.2014.12.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Callahan EA. <i>Current Status and Response to the Global Obesity Pandemic: Proceedings of a Workshop<\/i>. The National Academies Press, Washington (DC) (2019).","DOI":"10.17226\/25273"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. <i>Diabetes Res. Clin. Pract.<\/i>, <b>105<\/b>, 141\u2013150 (2014).","DOI":"10.1016\/j.diabres.2014.04.006"},{"key":"4","unstructured":"4) Tanaka K, Nakanishi T. Obesity as a risk factor for various diseases: necessity of lifestyle changes for healthy aging. <i>Applied Human Science: Journal of Physiological Anthropology<\/i>, <b>15<\/b>, 139\u2013148 (1996)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Lei F, Zhang XN, Wang W, Xing DM, Xie WD, Su H, Du LJ. Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice. <i>Int. J. Obes.<\/i> (Lond), <b>31<\/b>, 1023\u20131029 (2007).","DOI":"10.1038\/sj.ijo.0803502"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Nakashima T, Okuyama R, Kamiya Y, Matsumoto A, Iwatsuki M, Inahashi Y, Yamaji K, Takahashi Y, \u014cmura S. Trehangelins A, B and C, novel photo-oxidative hemolysis inhibitors produced by an endophytic actinomycete, <i>Polymorphospora rubra<\/i> K07-0510. <i>J. Antibiot.<\/i>, <b>66<\/b>, 311\u2013317 (2013).","DOI":"10.1038\/ja.2013.17"},{"key":"7","unstructured":"7) Inahashi Y, Shiraishi T, Palm K, Takahashi Y, \u014cmura S, Kuzuyama T, Nakashima T. Biosynthesis of Trehangelin in <i>Polymorphospora rubra<\/i> K07-0510: identification of metabolic pathway to Angelyl-CoA. <i>ChemBioChem<\/i>, <b>17<\/b>, 1442\u20131447 (2016)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lee H, Ahn J, Shin SS, Yoon M. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor alpha in high-fat-diet-fed C57BL\/6J mice. <i>Int. J. Obes.<\/i>, <b>43<\/b>, 1620\u20131630 (2018).","DOI":"10.1038\/s41366-018-0212-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. <i>Hepatology<\/i>, <b>51<\/b>, 121\u2013129 (2010).","DOI":"10.1002\/hep.23276"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) \u015eekero\u011flu V, Aydin B, Atli \u015eekero\u011flu Z, Ozdener Kompe Y. Hepatoprotective effects of capsaicin and alpha-tocopherol on mitochondrial function in mice fed a high-fat diet. <i>Biomedicine &amp; Pharmacotherapy<\/i>, <b>98<\/b>, 821\u2013825 (2018).","DOI":"10.1016\/j.biopha.2018.01.026"},{"key":"11","unstructured":"11) Blokhina O, Virolainen E, Fagerstedt KV. Antioxidants, oxidative damage and oxygen deprivation stress: a review. <i>Ann. Bot.<\/i>, <b>91<\/b>, 179\u2013194 (2003)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Dludla PV, Nkambule BB, Jack B, Mkandla Z, Mutize T, Silvestri S, Orlando P, Tiano L, Louw J, Mazibuko-Mbeje SE. Inflammation and oxidative stress in an obese state and the protective effects of gallic acid. <i>Nutrients<\/i>, <b>11<\/b>, 23 (2018).","DOI":"10.3390\/nu11010023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Iwabu M, Okada-Iwabu M, Yamauchi T, Kadowaki T. Adiponectin\/adipoR research and its implication for lifestyle-related diseases. <i>Frontiers in Cardiovascular Medicine<\/i>, <b>6<\/b>, 116 (2019).","DOI":"10.3389\/fcvm.2019.00116"},{"key":"14","unstructured":"14) Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. <i>Gut and Liver<\/i>, <b>6<\/b>, 149\u2013171 (2012)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Demir M, Lang S, Steffen HM. Nonalcoholic fatty liver disease - current status and future directions. <i>J. Dig. Dis.<\/i>, <b>16<\/b>, 541\u2013557 (2015).","DOI":"10.1111\/1751-2980.12291"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Wang J, Ryu HK. The effects of <i>Momordica charantia<\/i> on obesity and lipid profiles of mice fed a high-fat diet. <i>Nutr. Res. Pract.<\/i>, <b>9<\/b>, 489\u2013495 (2015).","DOI":"10.4162\/nrp.2015.9.5.489"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kim Y, Kwon MJ, Choi JW, Lee MK, Kim C, Jung J, Aprianita H, Nam H, Nam TJ. Anti-obesity effects of boiled tuna extract in mice with obesity induced by a high-fat diet. <i>Int. J. Mol. Med.<\/i>, <b>38<\/b>, 1281\u20131288 (2016).","DOI":"10.3892\/ijmm.2016.2695"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. <i>J. Clin. Endocrinol. Metab.<\/i>, <b>93<\/b> (Suppl. 1), S64\u2013S73 (2008).","DOI":"10.1210\/jc.2008-1613"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. TLR4 enhances TGF-beta signaling and hepatic fibrosis. <i>Nat. Med.<\/i>, <b>13<\/b>, 1324\u20131332 (2007).","DOI":"10.1038\/nm1663"},{"key":"20","unstructured":"20) Moschen AR, Molnar C, Geiger S, Graziadei I, Ebenbichler CF, Weiss H, Kaser S, Kaser A, Tilg H. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. <i>Gut<\/i>, <b>59<\/b>, 1259\u20131264 (2010)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hotamisligil GS. Inflammation and metabolic disorders. <i>Nature<\/i>, <b>444<\/b>, 860\u2013867 (2006).","DOI":"10.1038\/nature05485"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. <i>Nature<\/i>, <b>389<\/b>, 610\u2013614 (1997).","DOI":"10.1038\/39335"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. <i>J. Clin. Invest.<\/i>, <b>95<\/b>, 2409\u20132415 (1995).","DOI":"10.1172\/JCI117936"},{"key":"24","unstructured":"24) Shiota G, Tuchiya H. Mouse NASH model using retinoic acid receptor alpha. <i>Nippon Rinsho<\/i>, <b>64<\/b>, 1049\u20131055 (2006)."},{"key":"25","unstructured":"25) Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. <i>Hepatology<\/i>, <b>51<\/b>, 679\u2013689 (2010)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Tanaka N, Aoyama T, Kimura S, Gonzalez FJ. Targeting nuclear receptors for the treatment of fatty liver disease. <i>Pharmacol. Ther.<\/i>, <b>179<\/b>, 142\u2013157 (2017).","DOI":"10.1016\/j.pharmthera.2017.05.011"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Narala VR, Adapala RK, Suresh MV, Brock TG, Peters-Golden M, Reddy RC. Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor-alpha agonist. <i>J. Biol. Chem.<\/i>, <b>285<\/b>, 22067\u201322074 (2010).","DOI":"10.1074\/jbc.M109.085118"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Yu W, Xu L, Martin JG, Powell WS. Cellular infiltration and eicosanoid synthesis in brown Norway rat lungs after allergen challenge. <i>Am. J. Respir. Cell Mol. Biol.<\/i>, <b>13<\/b>, 477\u2013486 (1995).","DOI":"10.1165\/ajrcmb.13.4.7546778"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Altmann R, Hausmann M, Spottl T, Gruber M, Bull AW, Menzel K, Vogl D, Herfarth H, Scholmerich J, Falk W, Rogler G. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells. <i>Biochem. Pharmacol.<\/i>, <b>74<\/b>, 612\u2013622 (2007).","DOI":"10.1016\/j.bcp.2007.05.027"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. <i>Nature<\/i>, <b>393<\/b>, 790\u2013793 (1998).","DOI":"10.1038\/31701"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Nishimura T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF21, preferentially expressed in the liver. <i>Biochim. Biophys. Acta<\/i>, <b>1492<\/b>, 203\u2013206 (2000).","DOI":"10.1016\/S0167-4781(00)00067-1"},{"key":"32","unstructured":"32) Luquet S, Gaudel C, Holst D, Lopez-Soriano J, Jehl-Pietri C, Fredenrich A, Grimaldi PA. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes. <i>Biochim. Biophys. Acta<\/i>, <b>1740<\/b>, 313\u2013317 (2005)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Iwaisako K, Haimerl M, Paik YH, Taura K, Kodama Y, Sirlin C, Yu E, Yu RT, Downes M, Evans RM, Brenner DA, Schnabl B. Protection from liver fibrosis by a peroxisome proliferator-activated receptor \u03b4 agonist. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>109<\/b>, E1369\u2013E1376 (2012).","DOI":"10.1073\/pnas.1202464109"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammation properties. <i>Cell Metab.<\/i>, <b>6<\/b>, 137\u2013143 (2007).","DOI":"10.1016\/j.cmet.2007.06.010"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Jin D, Sun J, Huang J, Yu X, Yu A, He Y, Li Q, Yang Z. Peroxisome proliferator-activated receptor \u03b3 enhances adiponectin secretion <i>via<\/i> up-regulating DsbA-L expression. <i>Mol. Cell. Endocrinol.<\/i>, <b>411<\/b>, 97\u2013104 (2015).","DOI":"10.1016\/j.mce.2015.04.015"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/12\/42_b19-00668\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T03:25:47Z","timestamp":1575689147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/12\/42_b19-00668\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00668","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,1]]}}}